Nacel Energy Corporation (NCEN)

Revance Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Sep 30, 2011	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008	Mar 31, 2007
Net Income	-1.1	-0.66	-2.85	-2.33	-0.83	-0.03
Depreciation & Amortization	0.01	0.01	0.01	0	-	-
Other Amortization	1.16	1.77	0.44	-	-	-
Loss (Gain) on Equity Investments	-0.41	0.03	-	-	-	-
Asset Writedown	0.01	0.01	-	-	-	-
Stock-Based Compensation	0.13	0.12	0.19	1.17	-	-
Change in Accounts Payable	-0.02	-0.07	0.32	-0.07	0.08	-
Change in Other Net Operating Assets	-0.08	0.1	-0.19	0.01	0	-
Other Operating Activities	-0.28	-1.86	0.3	0	0.5	0
Operating Cash Flow	-0.58	-0.54	-1.77	-1.23	-0.24	-0.03
Capital Expenditures	-0	-	-0.02	-0.14	-0.03	-
Investment in Securities	-0.39	-	-	-	-	-0.01
Investing Cash Flow	-0.39	-	-0.02	-0.14	-0.03	-0.01
Short-Term Debt Issued	-	0.54	1.03	-	-	-
Long-Term Debt Issued	-	-	0.21	0.11	0.09	0.05
Total Debt Issued	0.78	0.54	1.24	0.11	0.09	0.05
Net Debt Issued (Repaid)	0.78	0.54	1.24	0.11	0.09	0.05
Issuance of Common Stock	-	-	0.17	1.44	0.55	-
Other Financing Activities	-	-	-0.12	-	-	-
Financing Cash Flow	0.78	0.54	1.29	1.55	0.64	0.05
Net Cash Flow	-0.18	-0.01	-0.51	0.18	0.36	0.02
Free Cash Flow	-0.58	-0.54	-1.79	-1.37	-0.27	-0.03
Free Cash Flow Per Share	-0.01	-0.02	-0.08	-0.06	-0.02	-0.00
Cash Interest Paid	0.04	0.06	0.04	0	-	-
Levered Free Cash Flow	-0.32	-0.65	0.36	-0.5	-	-
Unlevered Free Cash Flow	-1.33	-1.27	0.22	-0.49	-	-
Change in Net Working Capital	0.5	1	-1.33	0.07	-	-

Source: S&P Global Market Intelligence. Utility template. Financial Sources.